Preclinical Assessment of Thrombin-Preconditioned Human Wharton’s Jelly-Derived Mesenchymal Stem Cells for Neonatal Hypoxic-Ischaemic Brain Injury

0
54
The authors evaluated the tissue distribution and potential toxicity of thrombin-preconditioned human Wharton’s jelly-derived MSCs in animal models before the initiation of clinical trials.
[Journal of Cellular and Molecular Medicine]
Full Article